What does the evidence say about Xanthohumol Blood Glucose Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Xanthohumol Blood Glucose Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Safety and Tolerability of Xanthohumol in Adults With Crohn's Disease: Results of a Triple‐Masked, Randomized, Placebo‐Controlled Phase 2 Trial [Bradley R (2026); evidence level 2] - C k t t VCO VO 1 2 3 4 5 6 7 8 9 10 Xanthohumol is a prenylated chalcone that can be found at low concentrations in hops, which is why intake of xanthohumol via food is only possible in small quantities [,,]. [Brehmer‐Henkel Sara (2026); evidence level 2] - Smaller quantities of mixed metabolites containing sulfates and glucuronides as well as double glucuronide conjugates of xanthohumol and derived prenylated chalcones and flavonoids were also found. [Brehmer‐Henkel Sara (2026); evidence level 2] - By contrast, reductions of cardiometabolic risk parameters in glucose and lipid metabolism have been demonstrated in animal models [,]. [Brehmer‐Henkel Sara (2026); evidence level 2] - Intestinal absorption and consequently the bioavailability of many flavonoids are limited due to their hydrophobic properties [,,]. [Brehmer‐Henkel Sara (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.